May 22, 2024
How The U.S. Failed To Meet the China Challenge
It’s a rare subject of bipartisan agreement that China is the greatest strategic challenge facing the U.S., perhaps the greatest it has ever faced. And yet, despite a decade of admirations of both parties acknowledging the threat, we are woefully under-prepared for it. What can the next President learn from the mistakes of the recent past and how might he remedy them? On this episode of Free Expression from The Wall Street Journal podcast, Richard Fontaine and Robert Blackwill, foreign policy commentators and co-authors of a new book, “Lost Decade: The US Pivot to Asia and the Rise of Chinese Power” talk with Gerry Baker about what went wrong and how the next ad ministration must fix it.
Lost Decade: The U.S. Pivot to Asia and the Rise of Chinese Power is now available on Kindle. The book will be available in hardcover on June 11, 2024.
Listen to the full episode from The Wall Street Journal.
More from CNAS
-
Podcast
Defense / Indo-Pacific Security
Hellscape Taiwan: Drones, Deterrence, and the Future of Asymmetric DefenseStacie Pettyjohn joined the Irregular Warfare Podcast to examine how Taiwan could deter—or potentially defeat—a Chinese invasion by transforming the Taiwan Strait into an “unm...
By Stacie Pettyjohn
-
Video
Indo-Pacific Security / Energy, Economics & Security
Analysts Break Down Trump-Xi Meeting and Calls for Stability and CooperationFor perspective on President Trump's trip and the broader U.S.-China relationship, Geoff Bennett spoke with Myron Brilliant and Liza Tobin. Brilliant is at the DGA Group and i...
By Liza Tobin
-
Video
Indo-Pacific Security / Energy, Economics & Security
Rajdeep Sardesai Asks Big Question on US-ChinaThe debate on the Big Question, with Daniel Silverberg, adjunct senior fellow at the Center for a New American Security, explores whether Beijing holds the key to resolving th...
By Daniel Silverberg
-
China’s Pharmaceutical Weapon
Commentary
Until SAPIR is extended to biologically derived drugs, until the FDA clears the bovine pathway, and until at least one American-owned heparin manufacturer operates on US soil,...
By Jennifer Hendrixson White
